ClinicalMetric / Countries / Czech Republic / atrial fibrillation af
← 🇨🇿 Czech Republic Trials
🇨🇿 Czech Republic Country × Condition

atrial fibrillation af Clinical Trials in Czech Republic

Active clinical trials for atrial fibrillation af with research sites in Czech Republic. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 2 // Recruiting: 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇨🇿 Czech Republic

Active Trials in Czech Republic (2)

NCT06801392
Recruiting

Left Atrial Posterior Wall and Mitral Isthmus PF Ablation in Non-Paroxysmal AF Patients

Enrollment
50 pts
Country
🇨🇿 Czech Republic
Charles University, Czech Republic
View Trial →
NCT07610980
Recruiting

Optimal Shock Energy for Electrical Cardioversion of Atrial Fibrillation

Enrollment
400 pts
Country
🇨🇿 Czech Republic
Motol and Homolka University Hospit...
View Trial →

Frequently Asked Questions

How many atrial fibrillation af clinical trials are active in Czech Republic?
There are currently 2 active clinical trials for atrial fibrillation af with sites in Czech Republic, of which 2 are actively recruiting patients.
How can I join a atrial fibrillation af clinical trial in Czech Republic?
To join a atrial fibrillation af clinical trial in Czech Republic, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Czech Republic directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are atrial fibrillation af trials in Czech Republic?
Active atrial fibrillation af trials in Czech Republic span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Czech Republic Trials → Global atrial fibrillation af Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology